Work Chemical Exposure Linked to Breast Cancer Risk: Study
A recent Canadian study has found that exposure to certain textile and industrial substances could triple the chance that some women develop breast cancer.
The chemical exposure study, published in the April issue of the Occupational and Environmental Medicine medical journal, found that exposure to acrylic and nylon fibers, and monaromatic hydrocarbons, were linked to high increases in a woman’s cancer risk. The women most at risk were those who were exposed to the chemicals before the age of 36.
Researchers from the National Institute of Public Health in Montreal looked at 1,169 women between the ages of 50 and 75, with just under half of the women diagnosed with breast cancer after undergoing menopause. They found that women exposed to acrylic fibers in the workplace were seven times more likely to develop breast cancer than women who were not exposed. Exposure to nylon fibers doubled the risk of breast cancer.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Overall, researchers found that for every decade before the age of 36 that women were exposed to the fibers or to crude oil byproducts known as monaromatic hydrocarbons, their risk of tumors tripled.
“Our findings are consistent with the hypothesis that breast tissue is more sensitive to adverse effects if exposure occurs when breast cells are still proliferating,” researchers concluded. However, they cautioned that the findings of the study are far from definitive, saying that some findings could be due to chance or an undetected bias.
Additional research has been recommended on the link between chemical exposure and breast cancer.
"*" indicates required fields
More Top Stories
A Camp Lejeune non-Hodgkin's lymphoma lawsuit blames the death of a woman on her exposure to contaminated water from the military base.
Defendants want to divide the discovery process to focus on the causal links between hair relaxers and cancer.
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.